Evidence map›Paper›PMID 30883924›Full record

ArticleJournal of clinical laboratory analysis2019

The potential value of red blood cell distribution width in patients with invasive hydatidiform mole.

Lingling Zhang, Youjun Xie, Lingling Zhan

Abstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Feto-placental Unit: From Development to Function.Advances in experimental medicine and biology · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. COVID-19 and hydatidiform mole.American journal of reproductive immunology (New York, N.Y. : 1989) · 2020
    Review
  6. Hydatidiform mole in the era of COVID-19 pandemic. Is there an association?American journal of reproductive immunology (New York, N.Y. : 1989) · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lingling ZhangThe First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Youjun XieThe First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Lingling ZhanThe First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID https://orcid.org/0000-0002-5328-1622

Funding

Natural Science Foundation of Guangxi Zhuang Autonomous Region 2014GXNSFAA118276
6 · The paper itself

Abstract

backgroundRed blood cell distribution width (RDW) has attracted increasing attention in cancer. The aim of this study was to assess the changes of RDW in patients with invasive hydatidiform mole and analyze the relationship between RDW and invasive hydatidiform mole.

methodsA retrospective analysis was performed on 102 patients diagnosed as invasive hydatidiform mole in the First Affiliated Hospital of Guangxi Medical University from January 2009 to March 2018. A total of 120 healthy subjects were used as a control group. The Mann-Whitney U test was used for comparison between the invasive hydatidiform mole and control groups. Comparison of RDW with other blood parameters was performed using Spearman's. The area under the ROC curve (AUC) and 95% confidence interval (95% CI) were also determined.

resultsThe RDW, platelet-lymphocyte ratio (PLR), neutrophil-lymphocyte ratio (NLR), and absolute lymphocyte count were significantly elevated in the invasive hydatidiform mole group compared with control group. The hemoglobin (Hb) concentration, mean red blood cell volume (MCV) and platelet count (PLT) were significantly lower in invasive hydatidiform mole group than control group. Grade III and above invasive hydatidiform mole patients had higher levels of RDW than grade I and II patients. Correlation analysis showed that RDW was negatively correlated with Hb, MCV, NLR, and neutrophil count, but positively correlated with PDW and different stages of invasive hydatidiform mole. The ROC curve showed that the AUC of the RDW was 0.660 (95% CI 0.581-0.740; P < 0.01).

conclusionThis study reveals the potential value of RDW in invasive hydatidiform mole.

Indexed as

Erythrocyte IndicesAdultArea Under CurveCase-Control StudiesFemaleHumansHydatidiform Mole, InvasiveLymphocyte CountPlatelet CountPregnancyRetrospective StudiesUterine Neoplasmsinflammatory parametersinvasive hydatidiform moleneutrophil-lymphocyte ratioplatelet-lymphocyte ratiored blood cell distribution width

Identifiers

PMID30883924
PMCPMC6528643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.